Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and gabapentin for reducing spinal anesthesia complications in cesarean section
IRCT20230316057741N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of ketamine and gabapentin in cesarean delivery complication, postoperative nausea and vomiting (PONV) and Postoperative Headache (4 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoints: Severity of nausea and vomiting after surgery, Severity of headache after surgery and 1 more. Started May 2023; status: completed.
02
Drugs
ketaminegabapentin
03
Conditions
cesarean delivery complicationpostoperative nausea and vomiting (PONV)Postoperative Headache
Beyond the preview
Go deeper on IRCT20230316057741N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230316057741N1.